Healthcare -
Biotechnology - NASDAQ - US
$ 1.37
6.2 %
$ 387 M
Market Cap
-1.73
P/E
Price Target
Average
374.45%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
27.29%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Erasca, Inc.
Wall Street analysts predict an average 1-year price target for ERAS of $6.5 , with forecasts ranging from
a
low of
$6 to a high of $7 .
ERAS Lowest Price Target
Wall Street Target
6 USD
337.96%
ERAS Average Price Target
Wall Street Target
6.5 USD
374.45%
ERAS Highest Price Target
Wall Street Target
7 USD
410.95%
REVENUE FORECAST
Revenue Forecast Chart ERAS
EBIT FORECAST
EBIT Forecast Chart ERAS
NET INCOME FORECAST
Net Income Chart ERAS